More recent studies have suggested that there may be a role for more specific anti-inflammatory agents; a pilot study found improvements in cognition in patients with AD taking specific TNF-alpha inhibitors.44 Randomised controlled trials are needed to ascertain the benefit of anti-inflammatory antibody therapies in AD and DLB. This evidence concerns the gene TNF and Lewy body dementia.